Published in J Clin Rheumatol on September 01, 2009
Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol (2011) 1.23
Rhazes' prescriptions in treatment of gout. Iran Red Crescent Med J (2012) 0.97
Time Trends, Predictors, and Outcome of Emergency Department Use for Gout: A Nationwide US Study. J Rheumatol (2016) 0.75
Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications. Ther Adv Musculoskelet Dis (2016) 0.75
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) (2012) 5.22
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab (2007) 4.01
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) (2012) 2.83
Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. N Z Med J (2012) 2.37
Randomised trials in general practice--a New Zealand experience in recruitment. N Z Med J (2003) 2.23
Maori have worse outcomes after coronary artery bypass grafting than Europeans in New Zealand. N Z Med J (2013) 1.96
A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria. J Rheumatol (2013) 1.77
Decreased bone density in men on methadone maintenance therapy. Addiction (2010) 1.63
Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial. Bone (2012) 1.62
Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol (2006) 1.60
The management of acute coronary syndrome patients across New Zealand in 2012: results of a third comprehensive nationwide audit and observations of current interventional care. N Z Med J (2013) 1.60
Agreement between stereoscopic photographs, clinical assessment, Heidelberg retina tomograph and digital stereoscopic optic disc camera in estimating vertical cup:disc ratio. Clin Experiment Ophthalmol (2005) 1.58
Further development of an illness perception intervention for myocardial infarction patients: a randomized controlled trial. J Psychosom Res (2009) 1.58
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum (2012) 1.54
Benzbromarone therapy in management of refractory gout. N Z Med J (2005) 1.54
The skeletal effects of the tyrosine kinase inhibitor nilotinib. Bone (2011) 1.50
The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease. Respirology (2012) 1.49
Effect of providing information about normal test results on patients' reassurance: randomised controlled trial. BMJ (2007) 1.49
Acute primary angle closure attack does not cause an increased cup-to-disc ratio. Ophthalmology (2010) 1.45
Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population. J Rheumatol (2013) 1.45
Use of automated home blood pressure monitoring in pregnancy: is it safe? Am J Obstet Gynecol (2002) 1.40
Bone metabolism during long-term treatment with imatinib. Leuk Lymphoma (2013) 1.40
Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial. J Bone Miner Res (2010) 1.37
A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. Hum Mol Genet (2010) 1.33
Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum (2009) 1.32
Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis (2010) 1.31
Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab (2005) 1.30
National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) (2012) 1.30
Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities. N Z Med J (2004) 1.29
The gouty tophus: a review. Curr Rheumatol Rep (2015) 1.26
Outcome domains for studies of acute and chronic gout. J Rheumatol (2009) 1.24
Management of patients admitted with an Acute Coronary Syndrome in New Zealand: results of a comprehensive nationwide audit. N Z Med J (2004) 1.24
What do people with glaucoma know about their condition? A comparative cross-sectional incidence and prevalence survey. Clin Experiment Ophthalmol (2008) 1.23
A survey of indications, results and complications of surgery for tophaceous gout. N Z Med J (2002) 1.22
The genetic basis of hyperuricaemia and gout. Joint Bone Spine (2010) 1.20
Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002. N Z Med J (2010) 1.15
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women. J Clin Endocrinol Metab (2008) 1.14
Developing a provisional definition of flare in patients with established gout. Arthritis Rheum (2012) 1.10
'Choosing shoes': a preliminary study into the challenges facing clinicians in assessing footwear for rheumatoid patients. J Foot Ankle Res (2010) 1.08
Management of non ST-elevationacute coronary syndrome patients in New Zealand: a longitudinal analysis. Results from the New Zealand Acute Coronary Syndrome national audits of 2002, 2007 and 2012. N Z Med J (2016) 1.08
The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther (2012) 1.08
Clinical audit of foot problems in patients with rheumatoid arthritis treated at Counties Manukau District Health Board, Auckland, New Zealand. J Foot Ankle Res (2009) 1.07
Progress in measurement instruments for acute and chronic gout studies. J Rheumatol (2009) 1.06
Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res (Hoboken) (2011) 1.06
Imaging in gout--what can we learn from MRI, CT, DECT and US? Arthritis Res Ther (2011) 1.06
Can an illness perception intervention reduce illness anxiety in spouses of myocardial infarction patients? A randomized controlled trial. J Psychosom Res (2009) 1.05
Higher mortality in women undergoing coronary artery bypass grafting. N Z Med J (2013) 1.03
Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology (2002) 1.02
Pioglitazone increases bone marrow fat in type 2 diabetes: results from a randomized controlled trial. Eur J Endocrinol (2012) 1.01
Functional and biomechanical characteristics of foot disease in chronic gout: A case-control study. Clin Biomech (Bristol, Avon) (2010) 1.00
A picture of health--myocardial infarction patients' drawings of their hearts and subsequent disability: a longitudinal study. J Psychosom Res (2004) 1.00
Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI. Eur Heart J Acute Cardiovasc Care (2013) 1.00
Differences in practice and personal profiles between male and female ophthalmologists. Clin Experiment Ophthalmol (2007) 0.99
Foot pain, impairment, and disability in patients with acute gout flares: A prospective observational study. Arthritis Care Res (Hoboken) (2012) 0.99
The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol (2011) 0.98
Imaging of gout: findings and utility. Arthritis Res Ther (2009) 0.98
Risk factors for first presentation of glaucoma with significant visual field loss. Clin Experiment Ophthalmol (2008) 0.98
A review of uric acid, crystal deposition disease, and gout. Adv Ther (2014) 0.97
Predicting joint damage in rheumatoid arthritis using MRI scanning. Arthritis Res Ther (2009) 0.97
A profile of keratoconus in New Zealand. Cornea (2003) 0.96
Decreased bone turnover despite persistent secondary hyperparathyroidism during prolonged treatment with imatinib. J Clin Endocrinol Metab (2009) 0.96
Gout--what are the treatment options? Expert Opin Pharmacother (2009) 0.94
Bone erosions in patients with chronic gouty arthropathy are associated with tophi but not bone oedema or synovitis: new insights from a 3 T MRI study. Rheumatology (Oxford) (2013) 0.93
Characterization of new bone formation in gout: a quantitative site-by-site analysis using plain radiography and computed tomography. Arthritis Res Ther (2012) 0.93
Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology? J Rheumatol (2011) 0.92
Impact of television coverage on the number and type of symptoms reported during a health scare: a retrospective pre-post observational study. BMJ Open (2012) 0.92
The effect of an apparent change to a branded or generic medication on drug effectiveness and side effects. Psychosom Med (2012) 0.92
Assessment of cartilage loss at the wrist in rheumatoid arthritis using a new MRI scoring system. Ann Rheum Dis (2010) 0.92
Hyperinsulinemia in cord blood in mothers with type 2 diabetes and gestational diabetes mellitus in New Zealand. Diabetes Care (2006) 0.92
Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance. Arthritis Res Ther (2010) 0.92
Magnetic resonance imaging bone edema is not a major feature of gout unless there is concomitant osteomyelitis: 10-year findings from a high-prevalence population. J Rheumatol (2011) 0.92
The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial. Eur J Endocrinol (2013) 0.91
New insights into an old disease: advanced imaging in the diagnosis and management of gout. Postgrad Med J (2012) 0.91
A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate. J Clin Endocrinol Metab (2003) 0.91
Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Clin Endocrinol (Oxf) (2002) 0.91
The effects of commercially available footwear on foot pain and disability in people with gout: a pilot study. BMC Musculoskelet Disord (2013) 0.90
Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption. Arthritis Res Ther (2013) 0.89
Quadriceps arthrogenic muscle inhibition: the effects of experimental knee joint effusion on motor cortex excitability. Arthritis Res Ther (2014) 0.89
Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction (2013) 0.89
Prevalence and clinical factors associated with gout in patients with diabetes and prediabetes. Rheumatology (Oxford) (2011) 0.89
Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects. Arthritis Res Ther (2013) 0.89
Mechanisms of joint damage in gout: evidence from cellular and imaging studies. Nat Rev Rheumatol (2012) 0.89
A community-based model of care improves blood pressure control and delays progression of proteinuria, left ventricular hypertrophy and diastolic dysfunction in Maori and Pacific patients with type 2 diabetes and chronic kidney disease: a randomized controlled trial. Nephrol Dial Transplant (2010) 0.88
Obstacles to action in arthritis: a community case-control study. Int J Rheum Dis (2009) 0.88
Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials. J Rheumatol (2011) 0.88
Patients' drawings illustrate psychological and functional status in heart failure. J Psychosom Res (2007) 0.87
Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab (2010) 0.87
DECT urate deposits: now you see them, now you don't. Ann Rheum Dis (2012) 0.87
The PTPN22 locus and rheumatoid arthritis: no evidence for an effect on risk independent of Arg620Trp. PLoS One (2010) 0.87
Development of a computed tomography method of scoring bone erosion in patients with gout: validation and clinical implications. Rheumatology (Oxford) (2010) 0.87
Influence of HLA-B27 on the clinical presentation of psoriatic arthritis. J Rheumatol (2003) 0.87